fatty liver disease and semaglutide Why are GLP-1 agonists being used to treat patients with nonalcoholic disease? Semaglutide (Ozempic/Wegovy) dramatically improves fatty

HSA and FSA accounts cover all PlexusDx medications, providing additional savings for eligible patients and making premium weight loss therapy accessible without employer insurance barriers

The pipeline for GLP-1 receptor agonists is strong, with ongoing research into dual and triple hormone receptor agonists to improve efficacy and reduce side effects

The leveling off that happens with GLP-1 injections can be less frustrating and impactful

Male SpragueDawley rats were allocated to four groups: control (C), streptozotocin-induced diabetic (STZ), streptozotocin-induced diabetic rats treated with Retatrutide (STZR), and sham rats treated with Retatrutide alone (R)